↓ Skip to main content

Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis

Overview of attention for article published in Frontiers in immunology, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs
2 blogs
twitter
3 X users

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis
Published in
Frontiers in immunology, January 2020
DOI 10.3389/fimmu.2019.03052
Pubmed ID
Authors

Karissa L. Gable, Jeffrey T. Guptill

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 12%
Researcher 11 12%
Student > Bachelor 11 12%
Other 8 9%
Student > Master 7 8%
Other 11 12%
Unknown 32 35%
Readers by discipline Count As %
Medicine and Dentistry 16 18%
Biochemistry, Genetics and Molecular Biology 11 12%
Pharmacology, Toxicology and Pharmaceutical Science 8 9%
Neuroscience 7 8%
Immunology and Microbiology 7 8%
Other 10 11%
Unknown 32 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2021.
All research outputs
#2,609,510
of 25,387,668 outputs
Outputs from Frontiers in immunology
#2,636
of 31,539 outputs
Outputs of similar age
#61,744
of 473,273 outputs
Outputs of similar age from Frontiers in immunology
#63
of 603 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,539 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,273 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 603 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.